Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis  Akira Shimizu, Kazuhiko Yamada, David.

Slides:



Advertisements
Similar presentations
Volume 62, Issue 6, Pages (December 2002)
Advertisements

Volume 74, Issue 3, Pages (August 2008)
Volume 77, Issue 9, Pages (May 2010)
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 62, Issue 1, Pages (July 2002)
Volume 64, Issue 6, Pages (December 2003)
Volume 81, Issue 11, Pages (June 2012)
Volume 61, Issue 6, Pages (June 2002)
Volume 54, Issue 1, Pages (July 1998)
Volume 58, Issue 4, Pages (October 2000)
Volume 62, Issue 1, Pages (July 2002)
Volume 67, Issue 1, Pages (January 2005)
Chronic rejection of mouse kidney allografts
J.M. Henderson, S. al-Waheeb, A. Weins, S.V. Dandapani, M.R. Pollak 
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 70, Issue 7, Pages (October 2006)
Volume 62, Issue 6, Pages (December 2002)
Volume 58, Issue 6, Pages (December 2000)
Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice
Sickle Cell Nephropathy
Volume 75, Issue 10, Pages (May 2009)
Volume 57, Issue 6, Pages (June 2000)
Volume 54, Issue 3, Pages (September 1998)
Volume 84, Issue 4, Pages (October 2013)
Hans-Joachim Anders, Volker Vielhauer, Detlef Schlöndorff 
Volume 68, Issue 1, Pages (July 2005)
Volume 54, Issue 1, Pages (July 1998)
Volume 63, Issue 2, Pages (February 2003)
Volume 59, Issue 5, Pages (May 2001)
Marie Claire Gubler, Corinne Antignac  Kidney International 
Volume 63, Issue 5, Pages (May 2003)
Volume 57, Issue 2, Pages (October 2000)
Volume 64, Pages S39-S45 (October 2003)
Volume 70, Issue 8, Pages (October 2006)
Volume 58, Issue 2, Pages (August 2000)
Volume 71, Issue 1, Pages (January 2007)
Volume 57, Issue 3, Pages (March 2000)
Treatment of chronic tubulointerstitial disease: A new concept
Volume 63, Issue 4, Pages (April 2003)
Volume 70, Issue 10, Pages (November 2006)
Volume 57, Issue 1, Pages (January 2000)
Volume 61, Issue 6, Pages (June 2002)
Volume 62, Issue 2, Pages (August 2002)
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 60, Issue 1, Pages (July 2001)
Uromodulin storage disease
Volume 58, Issue 6, Pages (December 2000)
Role of CD8+ cells in the progression of murine adriamycin nephropathy
Nephrotic syndrome associated with hemophagocytic syndrome
Akira Shimizu, Kazuhiko Yamada, David H. Sachs, Robert B. Colvin 
Volume 55, Issue 3, Pages (March 1999)
Volume 59, Issue 3, Pages (March 2001)
Volume 73, Issue 9, Pages (May 2008)
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis  Gopala K. Rangan, Jeffrey W. Pippin, William.
Robert L. Chevalier, Michael S. Forbes, Barbara A. Thornhill 
Volume 72, Issue 2, Pages (July 2007)
Acute Kidney Injury and Proteinuria in a Patient With Diabetes and a Submandibular Mass  Prue Hill, MD, PhD, Prue Russell, MD, Christine Sammartino, MD,
B. Li, T. Morioka, M. Uchiyama, T. Oite  Kidney International 
Volume 62, Issue 2, Pages (August 2002)
Robert L. Chevalier, Barbara A. Thornhill, Alice Y. Chang 
CD4+ T cells: a potential player in renal fibrosis
Emerging role of B cells in chronic allograft dysfunction
Volume 68, Issue 3, Pages (September 2005)
Volume 62, Issue 3, Pages (September 2002)
Volume 58, Issue 4, Pages (October 2000)
Kirk J. Maurer, Robert P. Marini, James G. Fox, Arlin B. Rogers 
M.J. Butt, A.F. Tarantal, D.F. Jimenez, D.G. Matsell 
Volume 73, Issue 5, Pages (March 2008)
Volume 1, Issue 3, Pages (May 2019)
Alex B. Magil, Kathryn Tinckam  Kidney International 
Presentation transcript:

Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis  Akira Shimizu, Kazuhiko Yamada, David H. Sachs, Robert B. Colvin  Kidney International  Volume 61, Issue 5, Pages 1867-1879 (May 2002) DOI: 10.1046/j.1523-1755.2002.00309.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Interstitial fibrosis in the progression (A-C) and recovery groups (D-F) on days 30 (A, D), 60 (B, E), and 100 (C, F). In association with development of chronic rejection, progressive interstitial fibrosis occurs in the progression group. Chronic allograft glomerulopathy (arrowhead) and arteriopathy (arrow) developed by day 100. In contrast, only mild interstitial fibrosis remains after acute rejection in the recovery group. Masson Trichrome stain, ×250. Kidney International 2002 61, 1867-1879DOI: (10.1046/j.1523-1755.2002.00309.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Interstitial myofibroblast accumulation in the progression (A-F) and recovery (G, H) groups. In pretransplant controls (A), a small number of α-actin+ cells are seen in the interstitium; the media of arterioles is also α-actin+. During progression of chronic rejection, α-actin+ interstitial myofibroblasts progressively accumulate on days 30 (B) and 60 (C). Subsequently, by day 100 (D), α-actin+ cells gradually reduce with the development of interstitial fibrosis. α-Actin+ mesangial or smooth muscle cells are seen in the glomeruli or small arteries during the development of chronic allograft glomerulopathy (arrowhead) or arteriopathy (arrow). Both α-actin+ and PCNA+ proliferating myofibroblasts (arrow) are present around PTCs and tubules on days 18 (E) and 30 (F). In the recovery group, although α-actin+ myofibroblasts accumulate on days 30 (G), these cells reduce rapidly and only a few remain by day 100 (H). A-D, G, H: α-actin stain, ×250; E, F: double stain with α-actin (brown) and PCNA (black), ×600. Kidney International 2002 61, 1867-1879DOI: (10.1046/j.1523-1755.2002.00309.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Morphometric analysis of the number of proliferating myofibroblasts (PCNA+/α-actin+ cells) (A), the degree of α-actin+ interstitial area (score: 0-3) (B), and the degree of interstitial fibrosis (score: 0-3) (C) in the progression (•) and the recovery (○) groups. Preceding the development of interstitial fibrosis in the progression group, α-actin+/PCNA+ cells, and α-actin+ interstitial areas are significantly more prominent than in the recovery group. Values are expressed as mean ± SEM, *P < 0.05, **P < 0.01, ***P < 0.001. Kidney International 2002 61, 1867-1879DOI: (10.1046/j.1523-1755.2002.00309.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 4 CD3+ T cell infiltrate in the progression (A, B) and recovery (C, D) groups on days 18 (A, C) and 60 (B, D). Many CD3+ cells are seen in the early phase in both groups. Thereafter, the CD3+ cell infiltrate persists in the progression group. In contrast, in the recovery group, progressively diminishing T cell infiltrate is evident by day 60. CD3 stain; A, B ×400; C, D ×250. Kidney International 2002 61, 1867-1879DOI: (10.1046/j.1523-1755.2002.00309.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 5 TUNEL+ injured PTC endothelial cells (A-D) and tubular epithelial cells (E-H) in the progression (A, B, E, F) and recovery (C, D, G, H) groups on days 18 (A, C, E, G) and 60 (B, D, F, H). In both groups, many TUNEL+ damaged PTC endothelial cells and tubular epithelial cells (arrow) are seen with CD3+ T cell infiltrates in the early phase. These damaged cells are in contact with the CD3+ infiltrating T cells. In the progression group, numerous damaged cells remain by day 60, whereas these cells progressively diminish by day 60 in the recovery group. A-H: TUNEL (black) and CD3 (brown) double stain, ×800. Kidney International 2002 61, 1867-1879DOI: (10.1046/j.1523-1755.2002.00309.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 6 Morphometric analysis of the CD3+ T cell infiltrate (A, C), and TUNEL+ cells (B, D) in PTCs (A, B) and tubules (C, D) in the progression (•) and recovery (○) groups. CD3+ T cell infiltrates and the numbers of TUNEL+ cells in PTCs and tubules are significantly higher in the progression group than in the recovery group during development of interstitial fibrosis. Values are expressed as mean ± SEM, *P < 0.05, **P < 0.01, ***P < 0.001. Kidney International 2002 61, 1867-1879DOI: (10.1046/j.1523-1755.2002.00309.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 7 Peritubular capillary (PTC) injury (A-D, G, H) and α-actin+ interstitial myofibroblasts (E, F) in the progression (A-F) and recovery (G, H) groups on days 8 (A), 18 (B, E, G), 30 (F), 60 (C), and 100 (D, H). Mononuclear cell accumulation in PTCs (arrow) precedes interstitial inflammation on day 8 (A); injured PTCs (arrow) are separated from tubules by interstitial edema and/or cells on day 18 (B). These PTC alterations continue with duplication of BM (arrow) by day 60 (C), and finally, narrowed PTCs remain with thickened and duplicated BM (arrow) on day 100 (D). Initially, α-actin+ cells accumulate around injured PTCs on day 18 (E), and progressed into the interstitium between PTCs and tubules by day 30 (F). In the recovery group, damaged PTCs (arrow) with mononuclear cell infiltrates are found on day 18 (G); however, the mononuclear cell infiltrate resolves by day 100 with minimal capillary loss and duplicated BM (H). A-D, G, H: PAM stain; A, B, G: ×600, C, D, H, ×800; E, F: α-actin stain, ×600. Kidney International 2002 61, 1867-1879DOI: (10.1046/j.1523-1755.2002.00309.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 8 Electron microscopy reveals PTC alterations in the progression (A-F) and recovery (G, H) groups on days 18 (A), 30 (B, G), 60 (C), and 100 (D-F, H). (A) Destruction of PTCs (→) occurs with disruption of BM during acute rejection (×2000). (B) The remaining PTCs have activated endothelial cells. Myofibroblasts separate the PTCs from tubules and encompass the PTCs as smooth muscle cells do in arterioles (arteriolization of capillaries; ×2500). These PTC alterations continue until day 60 (C; ×2500), and the decreased size of PTCs persist on day 100 (D; ×3400) with lamination of BM (←) (E; ×2500). A dense collagen matrix accumulates between PTCs and tubules. (F) Loss of PTCs is evident around tubules (*) with interstitial fibrosis (×1000). In the recovery group, less marked PTC alterations are evident at day 30 (G; ×2000), and resolve by day 100 (H; ×2000). Kidney International 2002 61, 1867-1879DOI: (10.1046/j.1523-1755.2002.00309.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 9 Tubules with tubulitis, disrupted tubular basement membrane (TBM) and atrophy and α-actin+ myofibroblasts in the progression group. Severe tubulitis is characterized by prominent CD3+ cell infiltrate in the tubules on day 30 (A; CD3 stain, ×600), and is often accompanied by disrupted TBM (B; PAM stain, ×600). On days 18 (C) to 100 (D), loss of identifiable tubular structure is evident with interstitial inflammation and/or fibrosis (PAM stain, ×300). Tubules with tubulitis and disrupted BM (*) and atrophic tubules (arrowhead) are evident. Surrounding areas of severe tubulitis, many α-actin+ cells accumulate, and some of these cells (←) are present inside the damaged tubules on days 30 (E) and 60 (F), suggesting that the damaged tubules being incorporated into the fibrosis (α-actin stain, ×600). In areas of interstitial inflammation, loss of identifiable tubules (G) and tubular atrophy (H) are accompanied by many α-actin+ myofibroblasts on day 60 (α-actin stain, ×250). Kidney International 2002 61, 1867-1879DOI: (10.1046/j.1523-1755.2002.00309.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 10 Electron microscopy reveals disruption of the TBM in a severe tubulitis lesion. (A) The TBM is indicated by the arrows (↓). Between the arrows the TBM associated with a mononuclear cell infiltrate is not detected (×4300). (B) Exploded view from the section indicated by the arrowhead in panel A. A mononuclear cell migrates through TBM from the interstitium into the tubule with destruction of the TBM. The arrows also indicate that the TBM destruction is associated with a mononuclear cell infiltrate (×8700). Kidney International 2002 61, 1867-1879DOI: (10.1046/j.1523-1755.2002.00309.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 11 Frequency of tubules with tubulitis (A), disrupted TBM (B), and atrophy (C) in the progression (•) and the recovery (○) groups. The frequency of tubules with tubulitis, disrupted TBM, or atrophy in the progression group is significantly higher than in the recovery group during development of interstitial fibrosis. Values are expressed as mean ± SEM, *P < 0.05, **P < 0.01, ***P < 0.001. Kidney International 2002 61, 1867-1879DOI: (10.1046/j.1523-1755.2002.00309.x) Copyright © 2002 International Society of Nephrology Terms and Conditions